- Login
- Register & Subscribe
- Langue: EN FR DE
Regenerative Medicine
ESC-derived cells transplanted into the eye
Sunday 29 January 2012
The first embryonic stem-cell derived therapy for the eye has been safely transplanted into two patients with no signs of inflammation, rejection or tumourigenicity, according to a report published online in The Lancet on 24 January 2012.
Location
United States
Cardio3 BioSciences secures €3.1 million
Tuesday 10 January 2012
Cardio3 BioSciences SA has secured €3.1 million in new funding from the Walloon regional government of Belgium and from the European Seventh Framework Programme (FP7) to support development of its stem-cell technology.
Location
Belgium
ProFibrix reports on US Phase 2 study of sealant
Thursday 5 January 2012
ProFibrix BV of the Netherlands has announced that a Phase 2 US study of its sealant to stop bleeding during and after surgery reached its primary endpoint, confirming the results of an earlier Phase 2 study in the Netherlands.
Location
Netherlands
Sanofi gets rights to cartilage regeneration programme
Thursday 22 December 2011
Sanofi SA has agreed to pay up to €180 million to privately-held Scil Technology GmbH for exclusive rights to the German company’s preclinical programme for cartilage regeneration. The programme is based on the rhCD-RAP protein.
Location
Germany
Gene therapy shows benefit in patients with haemophilia B
Sunday 11 December 2011
Researchers from University College London and colleagues have reported the successful administration of a gene therapy to patients with haemophilia B. The study appears in the 10 December New England Journal of Medicine.
Location
United Kingdom
Transplantation of bioartificial trachea reported
Friday 9 December 2011
A team of European researchers has reported the successful transplantation of a synthetic trachea into a patient with tracheal cancer using a scaffold which was seeded with the patient’s own stem cells.
Location
Sweden
UK awards £8.5 million to regenerative medicine projects
Tuesday 6 December 2011
Fourteen research and development projects in the field of regenerative medicine are set to receive £8.5 million from the UK government as part of a drive to stimulate innnovation in the sector. The projects will be led by small and medium sized companies.
Location
United Kingdom
Interim results of cardiac stem cell trial said encouraging
Sunday 4 December 2011
A team of US scientists has reported interim results from a Phase 1 study of an autologous cardiac stem cell therapy which showed a substantial improvement in left ventricular systolic function in patients with heart disease. The findings appear in The Lancet.
Location
United States
Geron abandons stem cells
Wednesday 16 November 2011
Geron Corporation, which launched the first human study of an embryonic stem cell therapy in the west, has decided to leave the stem cell field citing the unfavourable financial environment. It is stopping its trial in patients with spinal cord injury.
Location
United States
Fibrin sealant meets primary endpoint in Phase 2 trial
Tuesday 15 November 2011
A sealant that has been developed to stop bleeding during and after surgery has met its primary endpoint in a Phase 2 trial of patients undergoing liver resection surgery, according to the developer, ProFibrix BV of the Netherlands.
Location
Netherlands
Select a News Category
Recent Appointments
Carolyn Compton named CEO of Critical Path Institute
Friday February 3 2012
John Perkins appointed UK chief scientific advisor
Monday January 23 2012
Briggs Morrison to lead global medicines development at AstraZeneca
Wednesday January 11 2012
Russell Greig appointed chair of AM-Pharma supervisory board
Wednesday January 4 2012
Mark Bodmer to head immunology at UCB
Tuesday January 3 2012